Literature DB >> 25684931

Sharp tooth induced sublingual hematoma in a patient with elevated international normalized ratio.

John Baliah1, Vishwanath Rangdhol1, David Livingstone2.   

Abstract

Sublingual hematoma secondary to anticoagulation is a rare fatal condition. Hemorrhagic complications of warfarin are well-known. This particular case is unique because the patient was on warfarin for the past 2 years but did not develop the sublingual hematoma. However, a trauma by an attrited sharp cusp triggered the episode of the sublingual hematoma in this patient. Being a medical emergency, patient was promptly hospitalized in cardiac care unit and managed by medical team. The patient was transfused with 2 units of fresh frozen plasma and warfarin was temporarily stopped for 4 days. Alternate day regimen of warfarin was started after 4 days, and international normalized ratio dropped to 3. In dental management, enameloplasty of the mandibular first molar tooth was done to prevent trauma and ulcer development in the floor of the mouth. The hematoma resolved, and no new hematoma formation was observed for a period of 6 months.

Entities:  

Keywords:  Enameloplasty; international normalized ratio; sublingual hematoma

Year:  2015        PMID: 25684931      PMCID: PMC4319335          DOI: 10.4103/0976-237X.149311

Source DB:  PubMed          Journal:  Contemp Clin Dent        ISSN: 0976-2361


  4 in total

1.  Massive sublingual haematoma following osseo-integrated implant placement in the anterior mandible.

Authors:  N Pigadas; P Simoes; J R Tuffin
Journal:  Br Dent J       Date:  2009-01-24       Impact factor: 1.626

2.  Massive sublingual hematoma secondary to anticoagulant therapy complicated by a traumatic denture: a case report.

Authors:  Anchal Puri; Muzzammil A Nusrath; Deepak Harinathan; Jamie Lyall
Journal:  J Med Case Rep       Date:  2012-04-10

Review 3.  Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

Authors:  C S Landefeld; R J Beyth
Journal:  Am J Med       Date:  1993-09       Impact factor: 4.965

Review 4.  The risk of bleeding with warfarin: a systematic review and performance analysis of clinical prediction rules.

Authors:  Karen Dahri; Peter Loewen
Journal:  Thromb Haemost       Date:  2007-11       Impact factor: 5.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.